{
    "Trade/Device Name(s)": [
        "GE Blood Glucose Monitoring System 333",
        "GE Blood Glucose Meter 333",
        "GE Blood Glucose Test Strip 333",
        "Rightest Control Solution GC550"
    ],
    "Submitter Information": "Bionime Corporation",
    "510(k) Number": "K143387",
    "Predicate Device Reference 510(k) Number(s)": [
        "K092052"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "May 4, 2015",
    "Summary Letter Received Date": "May 6, 2015",
    "Submission Date": "May 29, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GE Blood Glucose Meter 333"
    ],
    "Method(s)/Technology(ies)": [
        "Oxidase electrochemical sensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for GE Blood Glucose Monitoring System 333 for quantitative glucose measurement in capillary whole blood using oxidase electrochemical sensor",
    "Indications for Use Summary": "Intended for self-testing by people with diabetes at home to monitor effectiveness of diabetes control via quantitative glucose measurement in fresh capillary whole blood from fingertips, forearm, or palm; not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}